Literature DB >> 15003650

Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine.

Joseph A Bellanti1, Barbara J Zeligs, Julia Mendez-Inocencio, Ma Lourdes García-Garcia, Rocio Islas-Romero, Berna Omidvar, Jemal Omidvar, Gino Kim, Jorge Fernandez De Castro, Jaime Sepulveda Amor, Laura Walls, William J Bellini, José L Valdespino-Gomez.   

Abstract

The purpose of the present study was to compare serum and mucosal immune responses following either aerosol (Aer) or subcutaneous (SQ) measles immunization of Mexican school children. A cohort of 49 children from 6 to 7 years of age received either Aer ( n = 22) or SQ ( n = 27) Edmonston-Zagreb (EZ) measles vaccine. Serum and nasal secretions were collected prior to (Pre), 1 and 3 months (mos) intervals and analyzed for immunoglobulin (Ig) concentrations and measles specific Ig isotype-associated antibody by enzyme immunoassay (EIA). Serum and nasal IgG and IgA antibody responses were stimulated following immunization with live, attenuated EZ measles vaccine administered either by SQ or Aer routes but these responses were significantly greater by the Aer compared to the SQ route. These studies also suggest that the level of antibody in these secretions may serve as an important marker of immunity to measles and lend further support for aerosol immunization as an effective alternative vaccine delivery strategy for measles eradication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003650     DOI: 10.1016/j.vaccine.2003.09.032

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.

Authors:  Jakub K Simon; Karina Ramirez; Lilian Cuberos; James D Campbell; Jean F Viret; Alma Muñoz; Rosanna Lagos; Myron M Levine; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

2.  The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response.

Authors:  Antoine Minne; Jamila Louahed; Sybille Mehauden; Benoît Baras; Jean-Christophe Renauld; Rita Vanbever
Journal:  Immunology       Date:  2007-05-22       Impact factor: 7.397

Review 3.  An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children.

Authors:  Daisy Higginson; Evropi Theodoratou; Harish Nair; Tanvir Huda; Lina Zgaga; Suresh S Jadhav; Saad B Omer; Igor Rudan; Harry Campbell
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

4.  Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein.

Authors:  Nicolas Escriou; Benoît Callendret; Valérie Lorin; Chantal Combredet; Philippe Marianneau; Michèle Février; Frédéric Tangy
Journal:  Virology       Date:  2014-01-28       Impact factor: 3.616

5.  Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection.

Authors:  Rik L de Swart; Rory D de Vries; Linda J Rennick; Geert van Amerongen; Stephen McQuaid; R Joyce Verburgh; Selma Yüksel; Alwin de Jong; Ken Lemon; D Tien Nguyen; Martin Ludlow; Albert D M E Osterhaus; W Paul Duprex
Journal:  NPJ Vaccines       Date:  2017-08-01       Impact factor: 7.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.